• Home
  • HK inno.N Corporation

HK inno.N Corporation

About HK inno.N Corporation

HK inno.N is becoming a global No.1 pharmaceutical player in the global market by expanding exports and strengthening local business.A global pharmaceutical company that the world market watches Based on global sales and marketing competences that have been accumulated for years, we have rolled out the ethical drugs, active pharmaceutical ingredient (API), and Health & Beauty products across the globe. On the basis of new drug R&D for a range of success experiences and advance to global markets, we are expanding the exports to Japan, Southeast Asia, Central and South America, and Europe, and h...

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • KR
  • 2020
    On CPHI since
Company types
Pharmaceutical company
View company profile
Contact info
  • Pine Avenue Tower A, 100 , Eulji-ro, 04551, Seoul, Korea, Republic Of
Show contact info Hide contact info

Products from HK inno.N Corporation (24)

show all 24 products

HK inno.N Corporation Resources (1)

  • HK inno.N Corporation receives regulatory approval for first novel drug

    News HK inno.N Corporation receives regulatory approval for first novel drug

    Korean pharmaceutical firm HK inno.N Corp. said on Friday that its gastroesophageal reflux disease drug K-CAB has been approved by the Ministry of Food and Drug Safety, marking the first time for the company to launch an independently-developed novel drug under its name. HK inno.N plans to advance into overseas markets with its first novel drug, which has already been licensed out to China’s Shandong Luoxin Pharmaceutical Group in a 100 billion won ($89.7million)
    24 Sep 2020